The Effect of 0.01% Atropine Eye Drops on Axial Length and Refraction in Myopic Children Compared to a Control Group

ConditionFocus on Axial Length

Trial statusRecruiting

Trial phasePhase 2

Trial typeInterventional

Biological sexAll

Age4-16

SponsorLiaquat National Hospital & Medical College

About this trial

In this study, atropine 0.01% eye drops will be given to myopic children once at night daily for 6 months as compared to a control group to see the effect on axial length and refraction

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Children aged 4-16 years

Both genders

Myopia of baseline SER of -1.00D or more

Astigmatism less than or equal to -2.50D

Disqualifiers

Astigmatism ≥ 2.5 D

Anisometropia>1 D

Best corrected visual acuity < 0.5 (6/12)

Prior intraocular surgery

Trial design

Design model

Parallel

Treatments tested in this trial

Atropine 0.01% eye drops
Drug
Eye drops atropine 0.01% given once nightly to group A for 6 months

Treatment groups

60 Participants

are divided into 2 treatment groups

Group A: Group AActive comparator 1 intervention

Group B: Group BNo intervention 0 interventions

Trial outcomes

Primary outcomes

Change in axial length in mm

Axial length is measured at the time of recruiting the participants and after the end of study

Time frame

6 months

Change in refraction in Diopters

Refraction is measured at the start of study then after 6 months of study

Time frame

6 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Liaquat National Hospital & Medical College

Lead sponsor

Source ClinicalTrials.gov

Apply now